Victory Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$38.8M Sell
2,315,367
-1,094,775
-32% -$18.3M 0.03% 641
2025
Q1
$52.4M Buy
3,410,142
+386,668
+13% +$5.94M 0.05% 441
2024
Q4
$66.6M Buy
3,023,474
+1,094,759
+57% +$24.1M 0.07% 357
2024
Q3
$34.8M Buy
1,928,715
+21,764
+1% +$392K 0.03% 615
2024
Q2
$31M Buy
1,906,951
+107,909
+6% +$1.75M 0.03% 635
2024
Q1
$25.4M Buy
1,799,042
+1,760,656
+4,587% +$24.8M 0.02% 727
2023
Q4
$401K Buy
38,386
+6,886
+22% +$71.9K ﹤0.01% 2055
2023
Q3
$321K Sell
31,500
-748
-2% -$7.63K ﹤0.01% 2105
2023
Q2
$243K Sell
32,248
-8,198
-20% -$61.7K ﹤0.01% 2164
2023
Q1
$358K Sell
40,446
-8,815
-18% -$78K ﹤0.01% 2097
2022
Q4
$449K Sell
49,261
-126,499
-72% -$1.15M ﹤0.01% 2042
2022
Q3
$1.42M Sell
175,760
-15,956
-8% -$129K ﹤0.01% 1577
2022
Q2
$1.44M Buy
191,716
+6,662
+4% +$50.1K ﹤0.01% 1586
2022
Q1
$1.61M Buy
185,054
+54,505
+42% +$475K ﹤0.01% 1590
2021
Q4
$1.05M Buy
130,549
+10,851
+9% +$86.9K ﹤0.01% 1810
2021
Q3
$1.17M Buy
119,698
+1,167
+1% +$11.4K ﹤0.01% 1791
2021
Q2
$1.17M Sell
118,531
-20,611
-15% -$204K ﹤0.01% 1838
2021
Q1
$1.61M Buy
139,142
+20,056
+17% +$231K ﹤0.01% 1709
2020
Q4
$1.15M Buy
119,086
+35,886
+43% +$346K ﹤0.01% 1729
2020
Q3
$750K Buy
83,200
+18,939
+29% +$171K ﹤0.01% 1825
2020
Q2
$792K Sell
64,261
-73,483
-53% -$906K ﹤0.01% 1827
2020
Q1
$1.24M Buy
137,744
+50,551
+58% +$454K ﹤0.01% 1776
2019
Q4
$854K Buy
87,193
+6,006
+7% +$58.8K ﹤0.01% 1791
2019
Q3
$559K Buy
+81,187
New +$559K ﹤0.01% 1848
2016
Q3
Sell
-56,971
Closed -$2.86M 1830
2016
Q2
$2.86M Buy
56,971
+443
+0.8% +$22.3K 0.01% 646
2016
Q1
$3.03M Sell
56,528
-53,389
-49% -$2.86M 0.01% 628
2015
Q4
$7.22M Sell
109,917
-5,798
-5% -$381K 0.03% 514
2015
Q3
$6.53M Sell
115,715
-1,765
-2% -$99.6K 0.03% 535
2015
Q2
$6.94M Buy
117,480
+30,605
+35% +$1.81M 0.03% 538
2015
Q1
$5.41M Buy
+86,875
New +$5.41M 0.02% 533